Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Cavaller-Bellaubi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Clinical Pharmacology|February 14, 2020
The European Medicines Agency facilitates access to medicines in low- and middle-income countriesMaria Cavaller Bellaubi, Martin Harvey Allchurch, Clement Lagalice, et al.
The Lancet. Global Health|September 20, 2024
Access in the rare diseases landscapeAnneliene H Jonker, Maria Cavaller-Bellaubi, Yukiko Nishimura, et al.
Research Involvement and Engagement|November 28, 2024
A matrix tool to foster patient engagement in children, adolescents and young adults: report from a multistakeholder workshopMaria Cavaller-Bellaubi, Eva Degraeuwe, Johan Vande Walle, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 18, 2025
A multi-stakeholder perspective on medical devices for children and adolescents with type 1 diabetes: huge unmet needs for the smallestTorben Biester, Felix Reschke, Thomas Danne, et al.
Frontiers in Medicine|February 1, 2024
Drug repurposing for rare: progress and opportunities for the rare disease communityAnneliene Hechtelt Jonker, Daniel O'Connor, Maria Cavaller-Bellaubi, et al.
Orphanet Journal of Rare Diseases|June 12, 2023
Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCAMaria Cavaller-Bellaubi, Wills Hughes-Wilson, Šárka Kubinová, et al.
Therapeutic Innovation & Regulatory Science|May 10, 2021
Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for ActionMaria Cavaller-Bellaubi, Stuart D Faulkner, Bryan Teixeira, et al.
Journal of Crohn'S & Colitis|September 21, 2022
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and AdolescentsNicholas M Croft, Lissy de Ridder, Anne M Griffiths, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Clinical Pharmacology|February 14, 2020
The European Medicines Agency facilitates access to medicines in low- and middle-income countriesMaria Cavaller Bellaubi, Martin Harvey Allchurch, Clement Lagalice, et al.
The Lancet. Global Health|September 20, 2024
Access in the rare diseases landscapeAnneliene H Jonker, Maria Cavaller-Bellaubi, Yukiko Nishimura, et al.
Research Involvement and Engagement|November 28, 2024
A matrix tool to foster patient engagement in children, adolescents and young adults: report from a multistakeholder workshopMaria Cavaller-Bellaubi, Eva Degraeuwe, Johan Vande Walle, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|September 18, 2025
A multi-stakeholder perspective on medical devices for children and adolescents with type 1 diabetes: huge unmet needs for the smallestTorben Biester, Felix Reschke, Thomas Danne, et al.
Frontiers in Medicine|February 1, 2024
Drug repurposing for rare: progress and opportunities for the rare disease communityAnneliene Hechtelt Jonker, Daniel O'Connor, Maria Cavaller-Bellaubi, et al.
Orphanet Journal of Rare Diseases|June 12, 2023
Patients, payers and developers of Orphan Medicinal Products: lessons learned from 10 years' multi-stakeholder dialogue on improving access in Europe via MoCAMaria Cavaller-Bellaubi, Wills Hughes-Wilson, Šárka Kubinová, et al.
Therapeutic Innovation & Regulatory Science|May 10, 2021
Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for ActionMaria Cavaller-Bellaubi, Stuart D Faulkner, Bryan Teixeira, et al.
Journal of Crohn'S & Colitis|September 21, 2022
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and AdolescentsNicholas M Croft, Lissy de Ridder, Anne M Griffiths, et al.
Pageof 1